Kinapse CEO stepping down
September 24, 2010Kinapse
24 September, 2010London, UKThe Board of Directors of Kinapse Ltd. today announced that Co-founder Shalabh Kumar has stepped down as …
Matthew Newman joins Incuna
September 24, 2010Medical Communications Incuna, appointment, medical communications
Oxford, UK-based digital healthcare agency Incuna has appointed Matthew Newman as creative director.Matthew will oversee the creative department at Incuna, …
Europe committee rejects MS treatment Movectro
September 24, 2010Sales and Marketing Cladribine, Merck Serono Movectro
The Europe Medicines Agency has rejected Merck Serono’s new multiple sclerosis treatment Movectro, saying its benefits do not outweigh its …
Gene-targeting asthma drugs within a decade
September 24, 2010Research and Development asthma, genetic
Asthma treatments that target genetic variants found in people susceptible to the condition could be available within the next ten …
Novartis sells bladder treatment rights to Warner Chilcott
September 24, 2010Sales and Marketing Enablex, Novartis, Warner Chilcott
Novartis is to sell the US rights to market its overactive bladder treatment Enablex to Warner Chilcott. Novartis will receive …
Woolley Pau appoints senior creative
September 24, 2010Medical Communications Woolley Pau, appointment, medical communications
Iain Harrison has joined Woolley Pau as deputy creative director, bringing 24 years industry experience to the agency in a …
Avandia withdrawn in Europe, but remains in US
September 24, 2010Sales and Marketing Avandia, FDA, pharmacovigilance, safety
GSK’s diabetes drug Avandia is to be withdrawn from the market in Europe because of high levels of heart attack, …
Digital Pharma: Janssen unveils UK social media plans
September 23, 2010Medical Communications Digital Pharma blog, Facebook, Janssen, Twitter, psoriasis, social media, youtube
Janssen UK is to launch a wide-ranging social media campaign to raise awareness of the chronic skin condition psoriasis. The …
Extra phase II studies boost GSK’s Relovair
September 23, 2010COPD, GlaxoSmithKline, Relovair, asthma
GlaxoSmithKline has conducted additional phase II trials on its asthma/COPD drug Relovair to answer a number of safety and efficacy …
FDA committee backs Pradaxa
September 23, 2010Sales and Marketing Boehringer, Pradaxa, atrial fibrilation
An FDA committee has voted unanimously in favour of approving Pradaxa for stroke prevention in patients with atrial fibrillation. The …
Solid results for AstraZeneca’s oral RA drug
September 23, 2010Research and Development AstraZeneca, Rigel, fostamatinib, rheumatoid arthritis
AstraZeneca’s new oral treatment for rheumatoid arthritis has produced solid results in a phase II trial. Fostamatinib is the first …
Lilly names new VP of communications
September 23, 2010Medical Communications appointment, lilly, medical communications
Jeffrey Winton will next month join Lilly as vice president of communications and take a place on the company’s global …
Gilenya approved as new frontline MS treatment
September 22, 2010Research and Development, Sales and Marketing Cladribine, FDA, Novartis, gilenya
Novartis’ new multiple sclerosis treatment Gilenya has been approved by the FDA, and is set to significantly alter the way …
Lixisenatide shaping up to rival Victoza
September 22, 2010Research and Development Lixisenatide, Sanofi-Aventis, diabetes
Data for Sanofi-Aventis’ injectable lixisenatide suggests it could rival Novo Nordisk’s drug Victoza.Lixisenatide is a once-daily GLP-1 receptor agonist, and …
Outdated HRT website breaches Code
September 22, 2010Medical Communications ABPI, Code of Practice, PMCPA, Pfizer, Wyeth
A website which contained outdated information about the risk of using hormone replacement therapy has been found in breach of …
Tesco to sell cut-price Viagra
September 21, 2010Sales and Marketing Boots, Pfizer, Tesco, supermarket, viagra
Tesco has declared a price war in erectile dysfunction, announcing it will sell Viagra through its in-store pharmacies for less …
Digital Pharma: GSK takes drug information to Europe
September 21, 2010Medical Communications Digital Pharma blog, GlaxoSmithKline, digital patients
European patients can now get information on GlaxoSmithKline’s prescription medicines direct from the company through its expanded health.gsk.com website. The …
J&J’s Weldon will appear at next congressional hearing
September 21, 2010Manufacturing and Production Johnson & Johnson, manufacturing compliance, recalls
Johnson & Johnson chief executive William Weldon will appear in person at the next congressional hearing on the company’s wide-ranging …
Red Door boosts consumer health division
September 21, 2010Medical Communications Red Door, appointment, medical communications
London-based healthcare communications consultancy Red Door has boosted its consumer health division with two senior appointments. Rachel Vrettos has returned …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
